HIV accessory proteins: emerging therapeutic targets.

about

HIV accessory proteins: emerging therapeutic targets.

Item

http://www.wikidata.org/entity/Q36437528

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

HIV accessory proteins: emerging therapeutic targets.

@ast

HIV accessory proteins: emerging therapeutic targets.

@en

type

Item

label

HIV accessory proteins: emerging therapeutic targets.

@ast

HIV accessory proteins: emerging therapeutic targets.

@en

prefLabel

HIV accessory proteins: emerging therapeutic targets.

@ast

HIV accessory proteins: emerging therapeutic targets.

@en

P1476

HIV accessory proteins: emerging therapeutic targets

@en

P2093

N Sarver

http://www.w3.org/2001/XMLSchema#string

R H Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.

Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1

Subcellular localization of the Vif protein of human immunodeficiency virus type 1.

Molecular biology of the human immunodeficiency virus accessory proteins

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

P2888

bf03401585

P304

479-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03401585

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1995-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8529114

http://www.w3.org/2001/XMLSchema#string

P932

2229968

http://www.w3.org/2001/XMLSchema#string